Councils - Basic Science and Translational Research
Scientific Council on Basic Science & Translational Research Council Leadership Operating Board:COUNCIL CHAIR: NOT A COUNCIL MEMBER?
Council membership is open to all ISHLT members. Joining is easy. Simply login to the ISHLT Members Only Website
where you can update your membership profile and join any of the 11 Scientific Councils.
Transplant and Stem Cell Immunobiology Lab (TSI)
Stanford, CA, USAschrepfer@stanford.eduSonja Schepfer, MD, PhD is Director of the Transplant and Stem Cell Immunobiology (TSI)-Lab at the University Heart Center in Hamburg, Germany. She is also a Visiting professor of CT Surgery at the Stanford University, School of Medicine. Her laboratory investigates experimental cardiac and lung transplantation, myocardial restoration, and vascular biology and her specific area of interest is translational research of stem cell immunobiology and solid organ transplantation. She graduated in Medicine in 2002 at the Universities Wuerzburg and Munich (Germany) and received her PhD in Immunology in 2007. She completed her postdoctoral fellowship in CT Surgery at Stanford University and started the CT Surgery Transplant Immunobiology group in 2007. Dr. Schrepfer received numerous awards for her research in the field of transplant and stem cell immunology, including the "Norman E Shumway Career Development Award" in 2010 from the ISHLT, the "Rudolf Pichlmayr Award" in 2007 from the German Transplant Society,and the "DFG Heisenberg W3-Professorship" in 2009; more information is available at www.TSI-lab.de.COUNCIL VICE CHAIR:COUNCIL PAST CHAIR:
University of Missouri
Kansas City, Missouri, USAkgandy@mac.comKimberly Gandy, MD, PhD is an Associate Professor at the University of Missouri-Kansas City. Her primary area of basic and translational interest includes cellular therapy for tolerance induction using hematopoietic stem cells and myeloid progenitors. She is most recently involved in several translational projects regarding the use of mobile medical software for improving adherence in transplantation patients. Dr. Gandy earned her MD at Northwestern University in Evanston, Illinois, and her PhD in Immunology at Stanford University in Palo Alto, California. She completed general surgery and cardiovascular surgery residencies at Duke University Medical Center, and completed a cardiothoracic surgery postdoctoral research fellowship and pediatric cardiovascular surgery fellowship at Stanford University School of Medicine.BOARD OF DIRECTORS LIAISON:
Erasmus Medical Center
Rotterdam, THE NETHERLANDS
firstname.lastname@example.orgCarla C. Baan, PhD, is Professor and head of the Nephrology & Transplantation Laboratory at Erasmus Medical Center, University Hospital Rotterdam, The Netherlands. Dr Baan obtained her doctorate from Erasmus University, The Netherlands. Her position involves the supervision of doctorate research related to the role of cytokines, regulatory T cells, B cells, cell therapy and immunosuppressive drugs in clinical organ transplantation. Dr Baan is the first Past President of the European Society for Organ Transplantation (2013-2015), and a member of the board of the International Society for Heart and Lung Transplantation (2015-2016), the Transplantation Society, the Dutch Transplantation Society, the Dutch Immunology Society and the Dutch Nephrology Society. Currently, Dr Baan is an editor of Transplantation Immunology and is the executive editor basic sciences of the Transplantation Journal.COUNCIL WORKFORCE LEADERS:
University of Michigan Medical School
Ann Arbor, MI, USA
email@example.comBio coming soon...
University of Minnesota
Minneapolis, Minnesota, USA
firstname.lastname@example.orgBio coming soon...
University of Michigan
Ann Arbor, Michigan, USAplattjl@umich.eduJeffrey L. Platt, M.D. directs the Transplantation Biology Program and serves as Professor of Surgery, and Professor of Microbiology and Immunology at the University of Michigan. He investigates how T cells and B cells and their products interact with tissues to cause disease and to induce protection against further injury, how novel approaches might be used to replace organ function and restore immunological fitness and how fusion of one cell with another impacts on genomic integrity and cellular function. Dr. Platt is trained in Pediatrics (Childrens Hospital of LA) and nephrology (Univ Minnesota) and is a member of long standing of the ASN, AHA, the Association of American Physicians, IOM and the ISHLT.
Drexel University College of Medicine and Hahnemann University Hospital
Philadelphia, PA, USA
Heart Center North-Rhine Westphalia
Bad Oeynhausen, GERMANY
email@example.comBio coming soon...
The Proof Centre of Excellence
firstname.lastname@example.orgZsuzsanna Hollander is currently pursuing a PhD at UBC, Department of Pathology and Laboratory Medicine, under the supervision of Dr. Bruce McManus. Her work focuses on identifying novel biomarkers for the management of heart failure and heart transplant patients. Zsuzsa obtained a Masterís of Science degree in Computer Science from the University of British Columbia, Vancouver. She is also a certified Project Management Professional (PMP). Zsuzsa started working for the Biomarkers in Transplantation project in 2004 and transferred to the PROOF Centre of Excellence in 2008. She has expertise in genomics, proteomics and metabolomics data analyses as well as bioinformatics and data management.
Baylor University Medical Center
Dallas, TX, USA
email@example.comBio coming soon...
Alfred/Deakin Nursing Research Center
Melbourne, Victoria, AUSTRALIA
firstname.lastname@example.orgAssociate Professor Judy Currey coordinates ten critical care and perioperative postgraduate nursing programs at Deaking University, Melbourne Australia. In 2011 Judy was awarded an Australian Learning and Teaching Council citation for Outstanding Contributions to Student Learning. In 2010 Judy was awarded four teaching and innovation awards including the Deakin University Teacher of the Year. At The Alfred/Deakin Nursing Research Centre, Judy's research program is focused on nurses' decision making to optimize recovery after critical illness (heart and lung transplantation), medication quality and safety, and the impact of health technologies (MCS) on patient outcomes and careers. Judy also researches teaching and assessment methods to improve graduate's skills, knowledge and attributes in critical care nurses and is an international expert in Team-Based Learning.
Lucile Salter Packard Children's Hospital
Palo Alto, California, USA
email@example.comBio coming soon...
Los Angeles, CA, USA
firstname.lastname@example.orgTam Khuu is the Clinical Pharmacist for the Advanced Heart Failure/Mechanical Support/Heart Transplant Program at the Ronald Reagan UCLA Medical Center in Los Angeles, California. In addition to clinical services, she plays an active role in education of fellows, residents, and students. Dr. Khuu has authored several articles in the areas of therapeutic drug monitoring, immunosuppression pharmacology, and infectious disease. Dr. Khuu received her pharmacy training at the University of California, San Francisco and completed her residency training at City of Hope in Duarte, California. She is Board Certified in Pharmacotherapy.
The Prince Charles Hospital
Brisbane, Queensland, AUSTRALIA
61-7-31394000Daniel_Chambers@health.qld.gov.auDan Chambers, MBBS MRCP FRACP MD, is a Thoracic and Transplant Physician and Head of Research in the Queensland Lung Transplant Service, Prince Charles Hospital, Brisbane, Australia. He is also Associate Professor in the School of Medicine, University of Queensland, and Deputy Chair of the Metropolitan North Human Research and Ethics Committee. He is a member of the Lung Standing Committee for the Transplantation Society of Australia and New Zealand, and the Research Subcommittee for the Thoracic Society of Australia and New Zealand. His main research interests include the pathogenesis of chronic lung allograft dysfunction, early detection of lymphocytic bronchiolitis, lung metagenomics, adult lung disease complicating extreme preterm birth and cell therapy for advanced lung disease.